Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 243

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Increasing Racial and Ethnic Diversity in Cancer Clinical Trials: An American Society of Clinical Oncology and Association of Community Cancer Centers Joint Research Statement

Open access
Oyer, Randall A., Hurley, Patricia, Boehmer, Leigh, Bruinooge, Suanna Steeby, Levit, Kathryn, Barrett, Nadine, Benson, Al, Bernick, Lea Ann, Byatt, Leslie, Charlot, Marjory, Crews, Jennie, DeLeon, Kyle, Fashoyin-Aje, Lola, Garrett-Mayer, Elizabeth, Gralow, Julie R., Green, Sybil, Guerra, Carmen E., Hamroun, Leila, Hardy, Claudia M., Hempstead, Bridgette, Jeames, Sanford, Mann, Mel, Matin, Khalid, McCaskill-Stevens, Worta, Merrill, Janette, Nowakowski, Grzegorz S., Patel, Manali I., Pressman, Alice, Ramirez, Amelie G., Segura, Juanita, Segarra-Vasquez, Barbara, Hanley Williams, Jen, Williams, James E., Winkfield, Karen M., Yang, Eddy S., Zwicker, Victoria, Pierce, Lori J.·2022·Journal of Clinical Oncology

Abstract

A concerted commitment across research stakeholders is necessary to increase equity, diversity, and inclusion (EDI) and address barriers to cancer clinical trial recruitment and participation. Racial and ethnic diversity among trial participants is key to understanding intrinsic and extrinsic factors that may affect patient response to cancer treatments. This ASCO and Association of Community Cancer Centers (ACCC) Research Statement presents specific recommendations and strategies for the research community to improve EDI in cancer clinical trials. There are six overarching recommendations: (1) clinical trials are an integral component of high-quality cancer care, and every person with cancer should have the opportunity to participate; (2) trial sponsors and investigators should design and implement trials with a focus on reducing barriers and enhancing EDI, and work with sites to conduct trials in ways that increase participation of under-represented populations; (3) trial sponsors, researchers, and sites should form long-standing partnerships with patients, patient advocacy groups, and community leaders and groups; (4) anyone designing or conducting trials should complete recurring education, training, and evaluation to demonstrate and maintain cross-cultural competencies, mitigation of bias, effective communication, and a commitment to achieving EDI; (5) research stakeholders should invest in programs and policies that increase EDI in trials and in the research workforce; and (6) research stakeholders should collect and publish aggregate data on racial and ethnic diversity of trial participants when reporting results of trials, programs, and interventions to increase EDI. The recommendations are intended to serve as a guide for the research community to improve participation rates among people from racial and ethnic minority populations historically under-represented in cancer clinical trials. ASCO and ACCC will work at all levels to advance the recommendations in this publication.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1200/jco.22.00754

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 243

Metadata

Authors
Oyer, R. A., Hurley, P., Boehmer, L., Bruinooge, S. S., Levit, K., Barrett, N., Benson, A., Bernick, L. A., Byatt, L., Charlot, M., Crews, J., DeLeon, K., Fashoyin-Aje, L., Garrett-Mayer, E., Gralow, J. R., Green, S., Guerra, C. E., Hamroun, L., Hardy, C. M., Hempstead, B., Jeames, S., Mann, M., Matin, K., McCaskill-Stevens, W., Merrill, J., Nowakowski, G. S., Patel, M. I., Pressman, A., Ramirez, A. G., Segura, J., Segarra-Vasquez, B., Hanley Williams, J., Williams, J. E., Winkfield, K. M., Yang, E. S., Zwicker, V., & Pierce, L. J.
Venue
Journal of Clinical Oncology
Published
2022-07-01
Volume
40
Issue
19
Pages
2163-2171
ISSN
  • 0732-183X (ISSN-L)
  • 1527-7755
OpenAlex
W4280612868
Cited by
243
References
1
FWCI
41.17
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Increasing Racial and Ethnic Diversity in Cancer Clinical Trials: An American Society of Clinical Oncology and Association of Community Cancer Centers Joint Research Statement. https://app.cochat.ai/papers/10.1200/jco.22.00754
The paper
Oyer, R. A., Hurley, P., Boehmer, L., Bruinooge, S. S., Levit, K., Barrett, N., Benson, A., Bernick, L. A., Byatt, L., Charlot, M., Crews, J., DeLeon, K., Fashoyin-Aje, L., Garrett-Mayer, E., Gralow, J. R., Green, S., Guerra, C. E., Hamroun, L., Hardy, C. M., . . . Pierce, L. J. (2022). Increasing Racial and Ethnic Diversity in Cancer Clinical Trials: An American Society of Clinical Oncology and Association of Community Cancer Centers Joint Research Statement. Journal of Clinical Oncology. https://doi.org/10.1200/jco.22.00754

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.